Induction chemotherapy before chemoradiotherapy in locally advanced head and neck cancer: the future?
Paccagnella
Adriano
A
Divisione di Oncologia Medica, Ospedale di Venezia e Mestre, Mestre-Venezia, Italy. adriano.paccagnella@ulss12.ve.it
Mastromauro
Cataldo
C
D'Amanzo
Paola
P
Ghi
Maria Grazia
MG
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy*; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage; D018572:Disease-Free Survival; D000077143:Docetaxel; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy*; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D043823:Taxoids / Q000008:administration & dosage; D014481:United States / Q000453:epidemiology
D043823:Taxoids; D000077143:Docetaxel; D002945:Cisplatin; D005472:Fluorouracil